Showing results (171-180 of 308) with videos related to

Sort By:
Pageof 31
Communicable Diseases Intelligence (2018)|May 18, 2025
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2023Tanya R Diefenbach-Elstob, Olivia Lay, Tasoula Zakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2013
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesAudray K Harris, Joel R Meyerson, Yumiko Matsuoka, et al.
Plos Medicine|September 14, 2006
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsAmorsolo L Suguitan, Josephine McAuliffe, Kimberly L Mills, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Influenza and Other Respiratory Viruses|December 1, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 monthsFrancesca L Mordant, Olivia H Price, Rajeev Rudraraju, et al.
Communicable Diseases Intelligence (2018)|February 16, 2022
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in AustraliaNatasha K Brusco, Annette Alafaci, Jane Tuckerman, et al.
Plos Pathogens|August 18, 2017
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibodyKatherine V Houser, Andrew J Broadbent, Lisa Gretebeck, et al.
Plos Pathogens|April 14, 2010
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanismMatthew B Frieman, Jun Chen, Thomas E Morrison, et al.
Pageof 31